| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
1e-05 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
8e-05 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
9e-05 |
| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
9e-05 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |